ADHD Symptoms and Quality of Life Across a 12-Month Period in Children With ADHD: A Longitudinal Study

Abstract

Objective: To describe the relationship between ADHD symptom severity and quality of life (QoL) across three time points over a 12-month period and investigate whether sleep modifies this relationship. Method: Children aged 5 to 13 years with ADHD were recruited from 21 pediatric practices across Victoria, Australia (N = 392). Child QoL (parent-report) and ADHD symptoms (both parent- and teacher-report) were assessed at three time points (0, 6, and 12 months), and sleep was assessed at baseline (parent-report). Data were analyzed using Pearson’s correlations and autoregressive cross-lagged panel models. Results: Parent-reported ADHD symptoms predicted poorer QoL at each subsequent time point (r = −.10 to −.13), and a small bidirectional relationship was observed between teacher-reported ADHD symptoms and QoL from 6 to 12 months. Sleep moderated the relationship between ADHD symptoms and QoL. Conclusion: Clinicians need to look beyond core ADHD symptoms to other factors that may be influencing QoL in children with ADHD.

Keywords

ADHD quality of life symptom change

Get full access to this article

View all access options for this article.

References

Adamo

Seth

Coghill

(2015). Pharmacological treatment of attention-deficit/hyperactivity disorder: Assessing outcomes. Expert Review of Clinical Pharmacology, 8, 383-397. doi:10.1586/17512433.2015.1050379

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

Banaschewski

Johnson

Lecendreux

Zuddas

Adeyi

Hodgkins

. . . Coghill

D. R.

(2014). Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder. CNS Drugs, 28, 1191-1203. doi:10.1007/s40263-014-0193-z

Banaschewski

Soutullo

Lecendreux

Johnson

Zuddas

Hodgkins

. . . Coghill

(2013). Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder. CNS Drugs, 27, 829-840. doi:10.1007/s40263-013-0095-5

Bentler

(1990). Comparative fit indexes in structural models. Psychological Bulletin, 107, 238-246.

Cheng

J. Y.

Chen

R. Y.

J. S.

E. M.

(2007). Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents—Meta-analysis and meta-regression analysis. Psychopharmacology, 194, 197-209.

Coghill

(2010). The impact of medications on quality of life in attention-deficit hyperactivity disorder: A systematic review. CNS Drugs, 24, 843-866. doi:10.2165/11537450-000000000-00000

Coghill

Danckaerts

Sonuga-Barke

Sergeant

(2009). Practitioner review: Quality of life in child mental health—Conceptual challenges and practical choices. Journal of Child Psychology and Psychiatry, 50, 544-561.

Coghill

Hayward

Rhodes

Grimmer

Matthews

(2014). A longitudinal examination of neuropsychological and clinical functioning in boys with attention deficit hyperactivity disorder (ADHD): Improvements in executive functioning do not explain clinical improvement. Psychological Medicine, 44, 1087-1099.

10.

Coghill

Hodgkins

(2016). Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls. European Child & Adolescent Psychiatry, 25, 261-271.

11.

Curran

P. J.

Bollen

K. A.

(2001). The best of both worlds: Combining autoregressive and latent curve models. In Collins

Sayer

(Eds.), New methods for the analysis of change (pp. 107-135). Washington, DC: American Psychological Association.

12.

Danckaerts

Sonuga-Barke

E. J.

Banaschewski

Buitelaar

Döpfner

Hollis

. . . Steinhausen

H.-C.

(2010). The quality of life of children with attention deficit/hyperactivity disorder: A systematic review. European Child & Adolescent Psychiatry, 19, 83-105.

13.

DuPaul

G. J.

Power

T. J.

Anastopoulos

A. D.

Reid

(1998). ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation. New York, NY: Guilford Press.

14.

Escobar

Schacht

Wehmeier

P. M.

Wagner

(2010). Quality of life and attention-deficit/hyperactivity disorder core symptoms: A pooled analysis of 5 non-US atomoxetine clinical trials. Journal of Clinical Psychopharmacology, 30, 145-151. doi:10.1097/JCP.0b013e3181d21763

15.

Escobar

Soutullo

C. A.

Hervas

Gastaminza

Polavieja

Gilaberte

(2005). Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children. Pediatrics, 116, e364-e369.

16.

Hiscock

Sciberras

Mensah

Gerner

Efron

Khano

Oberklaid

(2015). Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: Randomised controlled trial. British Medical Journal, 350, h68.

17.

Bentler

(1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1-55.

18.

Lycett

Mensah

F. K.

Hiscock

Sciberras

(2015). Comparing subjective measures of behavioral sleep problems in children with ADHD: A cross-sectional study. Sleep Medicine, 16, 1377-1380.

19.

Lycett

Sciberras

Mensah

Gulenc

Hiscock

(2014). Behavioural sleep problems in children with attention-deficit/hyperactivity disorder (ADHD): Protocol for a prospective cohort study. BMJ Open, 4(2), e004070.

20.

Matza

L. S.

Rentz

A. M.

Secnik

Swensen

A. R.

Revicki

D. A.

Michelson

. . . . Kratochvil

C. J.

(2004). The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. Journal of Developmental & Behavioral Pediatrics, 25, 166-174.

21.

Mennin

Biederman

Mick

Faraone

(2000). Towards defining a meaningful anxiety phenotype for research in ADHD children. Journal of Attention Disorders, 3, 192-199.

22.

Muthen

(1998-2013). Mplus user’s guide. Los Angeles, CA: Muthen & Muthen.

23.

National Health & Medical Research Council. (2012). Clinical practice points on the diagnosis, assessment and management of attention deficit hyperactivity disorder in children and adolescents. Retrieved from www.clinicalguidelines.gov.au/portal/2152/clinical-practice-points-diagnosis-assessment-and-management-attention-deficit

24.

Newcorn

J. H.

Spencer

T. J.

Biederman

Milton

D. R.

Michelson

(2005). Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 240-248.

25.

Polanczyk

de Lima

M. S.

Horta

B. L.

Biederman

Rohde

L. A.

(2007). The worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry, 164, 942-948.

26.

Quach

Hiscock

Canterford

Wake

(2009). Outcomes of child sleep problems over the school-transition period: Australian population longitudinal study. Pediatrics, 123, 1287-1292.

27.

Riley

A. W.

Spiel

Coghill

Döpfner

Falissard

Lorenzo

M. J.

. . . Ralston

S. J.

(2006). Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment. European Child & Adolescent Psychiatry, 15, i38-i45.

28.

Sawyer

M. G.

Whaites

Rey

J. M.

Hazell

P. L.

Graetz

B. W.

Baghurst

(2002). Health-related quality of life of children and adolescents with mental disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 530-537.

29.

Sciberras

Efron

Gerner

Davey

Mensah

Oberklaid

Hiscock

(2010). Study protocol: The sleeping sound with attention-deficit/hyperactivity disorder project. BMC Pediatrics, 10, Article 101.

30.

Sciberras

Lycett

Efron

Mensah

Gerner

Hiscock

(2014). Anxiety in children with attention-deficit/hyperactivity disorder. Pediatrics, 133, 801-808.

31.

Silverman

W. K.

Albano

A. M.

(2006). Anxiety Disorders Interview Schedule (ADIS-IV) Child Interview Schedule. Oxford, UK: Oxford University Press.

32.

Sung

Hiscock

Sciberras

Efron

(2008). Sleep problems in children with attention-deficit/hyperactivity disorder: Prevalence and the effect on the child and family. Archives of Pediatrics & Adolescent Medicine, 162, 336-342.

33.

Varni

J. W.

Burwinkle

T. M.

(2006). The PedsQL™ as a patient-reported outcome in children and adolescents with Attention-Deficit/Hyperactivity Disorder: A population-based study. Health and Quality of Life Outcomes, 4, 26.

34.

Varni

J. W.

Limbers

C. A.

Burwinkle

T. M.

(2007). Parent proxy-report of their children’s health-related quality of life: An analysis of 13,878 parents’ reliability and validity across age subgroups using the PedsQL™ 4.0 Generic Core Scales. Health and Quality of Life Outcomes, 5(1), 2.

35.

Varni

J. W.

Seid

Kurtin

P. S.

(2001). PedsQL™ 4.0: Reliability and validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in healthy and patient populations. Medical Care, 39, 800-812.

36.

Wehmeier

P. M.

Schacht

Escobar

Savill

Harpin

(2010). Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials. Child and Adolescent Psychiatry and Mental Health, 4, 30. doi:10.1186/1753-2000-4-30

37.

WHOQOL Group. (1995). The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization. Social Science & Medicine, 41, 1403-1409.